BCAS3-BCAS4 gene fusion, which has previously been reported in breast carcinomas, was validated as the product of a fusion gene between BCAS4 and BCAS3, which resulted from amplification followed by a translocation event between the two loci chr20q13 and chr17q2372. This evidence concerns the gene BCAS4 and breast carcinoma.